Leukemia
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
How I Treat Older Adults With B-ALL in 2020: Is OS Better With Blinatumomab/Inotuzumab vs. ChemoRx in R/R Disease? What Is the MRD Negativity With HCVD-Ino-Blina? Does Venetoclax Improve Response?
FEATURING
Elias Jabbour
- 21 views
- December 22, 2020
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
Treatment Consideration of CLL: Evaluation of BTK Inhibitor in the Frontline Setting
FEATURING
John Byrd
- 124 views
- December 14, 2020
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Update on Familial AML: What Are the Current Recommendations?
FEATURING
Courtney D. DiNardo
- 12 views
- December 11, 2020
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
Intensive vs. Non-Intensive Approach in Adults With Ph+ ALL: Does Chemo-Free Induction / Consolidation With Dasatinib & Blinatumomab Improve OS and Induce High Rates of MRD Negativity?
FEATURING
Sabina Chiaretti
- 14 views
- December 3, 2020
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on AlloHSCT in AML: Are There Benefits to Chemo in Older Adults? Should We Use CC-486 in the Maintenance Setting? What Are the Outcomes With Favorable Risk? Is Intensive Induction Always Necessary?
FEATURING
Uma Borate
- 119 views
- November 13, 2020
- 1
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Highlights on CAR-T in ALL: What Are the Desired Characteristics of CAR-T for Adults? How Many Patients Achieve MRD Negativity? Does AUTO1 Have the Potential as a Stand-Alone Therapy?
FEATURING
Martin Pule
- 60 views
- November 9, 2020
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)
2020 SOHO Updates on AML: How Is Drug Development Affecting Treatment? Is Venetoclax Still Superior Than Others? Which Practices Can We Apply From MM Management? Can We Use MRD for Clinical Decisions?
FEATURING
Amer Zeidan
- 31 views
- October 29, 2020